<DOC>
	<DOCNO>NCT01315899</DOCNO>
	<brief_summary>Raynaud 's phenomenon ( RP ) disorder digital blood vessel result episodic impairment blood flow . During attack RP commonly affect hands foot artery contract briefly limit blood flow ( call vasospasm ) deprive blood skin turn white blue . The aim study prove concept ORM-12741 prevent blood vessel spasm .</brief_summary>
	<brief_title>Efficacy ORM-12741 Prevention Raynaud 's Phenomenon</brief_title>
	<detailed_description />
	<mesh_term>Raynaud Disease</mesh_term>
	<criteria>Written inform consent obtain Age 1075 year ( inclusive ) Body mass index ( BMI ) 1030 kg/m2 ( inclusive ) Male female patient diagnosis active Raynaud 's phenomenon ( RP ) secondary systemic sclerosis . Active RP define history cold sensitivity associate colour change cyanosis pallor , well least 6 attack weekly winter month . Diagnosis systemic sclerosis define European League Against Rheumatism ( EULAR ) criterion . Stable symptom RP medication requirement within 2 month prior screen Negative pregnancy test female childbearing potential Treatment nitrate Treatment calcium channel blocker ( CCBs ) indication relief RP symptom Treatment calcium channel blocker ( CCBs ) relief RP symptoms opinion investigator stop screen visit end last experimental session Changes dose vasoactive medication within 1 month prior screen study Smoking smoke cessation use nicotine product within 3 month prior screen Current active ischemic digital ulcer and/or tissue gangrene History sympathectomy Upper extremity deep vein thrombosis lymphoedema within 3 month prior screen . Clinically significant cardiovascular , pulmonary , gastrointestinal , hepatic , renal , neurological , psychiatric malignant disorder major concurrent illness opinion investigator would interfere interpretation study result constitute health risk subject he/she take part study Supine Heart rate ( HR ) &gt; 100 beat per minute ( bpm ) 10 minute rest screen Supine systolic BP ( SBP ) &gt; 160 diastolic BP ( DBP ) &gt; 100 mmmHg 10 minute rest screen visit Any abnormal value laboratory , vital sign ECG may opinion investigator interfere interpretation study result cause health risk subject he/she take part study . Pregnant breast feed consider pregnancy next 4 month Female subject child bear potential ( i.e . menstruate less 2 year post menopausal ) use proper contraception ( hormonal contraception , intrauterine device [ IUD ] surgical sterilisation , spermicidal foam conjunction condom male partner ) Subjects preplanned elective surgery estimate study period Blood donation loss significant amount blood within 30 day prior screen Participation drug study within 30 day prior screen Known hypersensitivity active substance excipients drug Recent current ( suspect ) drug abuse Recent current alcohol abuse ( regular drinking 14 unit per week female 21 unit per week male 1 unit= 4cl spirit equivalent ) Inability refrain consume caffeinecontaining beverage least 12 hour prior treatment visit e.g propensity get headache refrain caffeinecontaining beverage Inability participate treatment period Unsuitable vein repeat venipuncture cannulation The subject able swallow test capsule screen visit Any condition opinion investigator would interfere interpretation study result constitute health risk patient he/she take part study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Raynaud 's phenomenon</keyword>
	<keyword>Systemic sclerosis</keyword>
</DOC>